Related content

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 963-972

Spandidos Publications

Access to resources Recommend Favorite

NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells

By      

Molecular Medicine Reports, Vol. 7, Iss. 5, 2013-01 ,pp. : 1641-1645

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration

By                  

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 580-584

Spandidos Publications

Access to resources Recommend Favorite

The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib

By Yerlikaya Azmi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1385-1392

Springer Publishing Company

Access to resources Recommend Favorite